Smith & Nephew plucks its new CFO from AstraZeneca

Global medical technology business Smith & Nephew has appointed a director at AstraZeneca as its new Chief Financial Officer (CFO) to replace Adrian Hennah when he leaves at the end of December.

Global medical technology business Smith & Nephew has appointed a director at AstraZeneca as its new Chief Financial Officer (CFO) to replace Adrian Hennah when he leaves at the end of December.

Julie Brown, who has worked for AstraZeneca for 25 years, will formally takeover the role in early February.

At AstraZeneca she held a number of senior financial and management positions including Regional Vice President of Latin America, Marketing Company President in Portugal, Vice President of Corporate Strategy and Research, and Development Chief Financial Officer. Most recently she held the role of interim CFO.

Olivier Bohuon, Chief Executive Smith & Nephew, said: "Julie is an outstanding leader who brings to Smith & Nephew exceptional financial expertise and a deep knowledge of the healthcare market. Her ability to build teams and her broad experience working across geographies and within senior commercial roles will undoubtedly enable her to be a strong business partner. I look forward to working closely together as we continue to reshape Smith & Nephew for future success."

It was announced in mid-September that Hennah had accepted a job at consumer goods multi-national Reckitt Benckiser.

The share price rose 0.08% to 641p by 13:37.

NR

Recommended

Share tips of the week – 19 August
Share tips

Share tips of the week – 19 August

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
19 Aug 2022
How to invest in smart factories as the “fourth industrial revolution” arrives
Share tips

How to invest in smart factories as the “fourth industrial revolution” arrives

Exciting new technologies and trends are coming together to change the face of manufacturing. Matthew Partridge looks at the companies that will drive…
18 Aug 2022
How to invest today? Look to the past, not the future
Investment strategy

How to invest today? Look to the past, not the future

The past few years have seen so many changes to our way of life that many people said we had entered a “new normal”. But as it turns out, the new norm…
18 Aug 2022
A new legal headache for Haleon
Stocks and shares

A new legal headache for Haleon

Haleon, GSK’s former consumer-products arm, spun off last month, has made a dismal debut on the stockmarket.
17 Aug 2022

Most Popular

How to protect your wealth as inflation hits new record highs
Investment strategy

How to protect your wealth as inflation hits new record highs

UK inflation has hit a new record high of 10.1%. It's going to hurt, says Dominic Frisby. Here's how you can protect your wealth.
17 Aug 2022
How to cut your energy bill
Personal finance

How to cut your energy bill

The energy-price cap will almost double in the autumn. What does this mean for your money, and how can you alleviate the squeeze? Ruth Jackson-Kirby h…
17 Aug 2022
Are GSK’s legal troubles a threat to the firm’s survival?
Biotech stocks

Are GSK’s legal troubles a threat to the firm’s survival?

Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargr…
16 Aug 2022